Stay updated with breaking news from Rating Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patients with amyotrophic lateral sclerosis carrying variants of the gene glucocerebrosidase were more likely to show cognitive decline compared to noncarriers.
An FDA panel has voted on the question of whether evidence supports the approval of sodium phenylbutyrate/taurursodiol (AMX0035) for ALS.
A US Food and Drug Administration advisory committee is unconvinced by that a new drug for amyotrophic lateral sclerosis is effective.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
BrainStorm is generating stem cells to test its ALS drug in a genetic subpopulation after missing the mark in a Phase III trial.